Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease‐Activated Receptor Pathway
Authors:
Open Access
- 16 April 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (8) , e012195
Abstract
Background: An enhanced renin‐angiotensin system causes hypertensive renal damage. Factor Xa not only functions in the coagulation cascade but also activates intracellular signaling through protease‐activated receptors ( PAR ). We investigated the effects of rivaroxaban, a factor Xa inhibitor, on hypertensive renal damage in hypertensive mice overexpressing renin (Ren‐TG). Methods and Results: The 12‐ to 16‐week‐old Ren‐TG and wild‐type mice were orally administered with or without 6 or 12 mg/kg of rivaroxaban for 1 or 4 months. Plasma factor Xa was significantly increased in the Ren‐TG compared with the wild‐type mice and was reduced by 12 mg/kg of rivaroxaban ( P P P <0.01). Moreover, rivaroxaban treatment attenuated histologic changes of glomerular hypertrophy, mesangial matrix expansion, effacement of the podocyte foot process, and thickened glomerular basement membrane in the Ren‐TG. The renal expression of PAR ‐2 was increased in the Ren‐TG, but was inhibited with rivaroxaban treatment. In vitro study using the human podocytes showed that the expressions of PAR ‐2 and inflammatory genes and nuclear factor–‐κB activation were induced by angiotensin II stimulation, but were inhibited by rivaroxaban. PAR ‐2 knockdown by small interfering RNA also attenuated the PAR ‐2‐related inflammatory gene expressions. Conclusions: These findings indicate that rivaroxaban exerts protective effects against angiotensin II–induced renal damage, partly through inhibition of the PAR ‐2 signaling‐mediated inflammatory response.Keywords
This publication has 39 references indexed in Scilit:
- Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque PhenotypePLOS ONE, 2012
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney DiseaseNew England Journal of Medicine, 2012
- Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive AnticoagulationJournal of the American Society of Nephrology, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Lipopolysaccharide-Triggered Acute Aggravation of Mesangioproliferative Glomerulonephritis through Activation of Coagulation in a High IgA Strain of ddY MiceNephron Experimental Nephrology, 2009
- The role of podocytes in proteinuriaNephrology, 2007
- Synaptopodin Protects Against Proteinuria by Disrupting Cdc42:IRSp53:Mena Signaling Complexes in Kidney PodocytesThe American Journal of Pathology, 2007
- The Cardiovascular Actions of Protease-Activated ReceptorsMolecular Pharmacology, 2005
- Isolate diffuse thickening of glomerular capillary basement membrane: a renal lesion in prediabetes?Laboratory Investigation, 2004
- The renin-angiotensin-aldosterone system and fibrinolysisJournal of the Renin-Angiotensin-Aldosterone System, 2000